Is Aardvark Therapeutics, Inc. Common Stock (AARD) undervalued? · $284.4M cap
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
This page asks whether Aardvark Therapeutics, Inc. Common Stock (AARD) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Without a cached income statement, “undervalued AARD” is a slogan. Wait for the print.
AARD currently screens at market cap $284.4M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new AARD 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare AARD to the stock page model before you treat a low multiple as a gift.
Not investment advice.